Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Remdesivir, HCQ don't help Covid patients: WHO study

Remdesivir and hydroxychloroquine, two drugs being commonly used to treat Covid, had little or no effect on patients' length of hospital stay or chances of survival, says WHO

Remdesivir and hydroxychloroquine, two drugs being commonly used to treat Covid, had little or no effect on patients' length of hospital stay or chances of survival, a WHO trial has found. news agency Reuters has reported. The WHO evaluated the effects of four potential drug regimens, including remdesivir, hydroxychloroquine, anti-HIV drug combination lopinavir/ritonavir and interferon, in 11,266 adult patients across more than 30 countries. The study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital stay, the WHO said on Thursday.

Remdesivir and hydroxychloroquine, two drugs being commonly used to treat Covid, had little or no effect on patients' length of hospital stay or chances of survival, a WHO trial has found. news agency Reuters has reported. Antiviral drug Remdesivir, among the first to be used as a treatment for Covid-19, was one of the drugs recently used to treat US President Donald Trump's coronavirus infection. The WHO evaluated the effects of four potential drug regimens, including remdesivir, hydroxychloroquine, anti-HIV drug combination lopinavir/ritonavir and interferon, in 11,266 adult patients across more than 30 countries. The study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital stay, the WHO said on Thursday.

hydroxychloroquine

Categories